Hepatitis B Virus Infection among People Who Use Illicit Drugs: Prevalence, Genotypes and Risk Factors in the State of Amapá, Northern Brazil

References

• Abdalla, R. R., Madruga, C. S., Ribeiro, M., Pinsky, I., Caetano, R., & Laranjeira, R. (2014). Prevalence of cocaine use in Brazil: Data from the II Brazilian national alcohol and drugs survey (BNADS). Addictive Behaviors, 39(1), 297–301. doi:10.1016/j.addbeh.2013.10.019
   PubMed Web of Science ®Google Scholar
• Akselrod, H., Grau, L. E., Barbour, R., & Heimer, R. (2014). Seroprevalence of HIV, hepatitis B Virus, and HCV among injection drug users in Connecticut: Understanding infection and coinfection risks in a nonurban population. American Journal of Public Health, 104(9), 1713–1721. doi:10.2105/AJPH.2013.301357
   PubMed Web of Science ®Google Scholar
• Andrade, A. P., Pacheco, S. D. B., Silva, F. Q., Pinheiro, L. M. L., Castro, J. A. A., Amaral, C. E. M., Hermes, R. B., Fischer, B., Pinho, J. R. R., Lemos, J. A. R., & Oliveira-Filho, A. B. (2017). Characterization of hepatitis B virus infection in illicit drug users in the Marajó Archipelago, northern Brazil. Archives of Virology, 162(1), 227–233. doi:10.1007/s00705-016-3060-z
   PubMed Web of Science ®Google Scholar
• Baptista, C. J., Dourado, I., de Andrade, T. M., Brignol, S., Bertoni, N., & Bastos, F. I. (2018). HIV prevalence, knowledge, attitudes, and practices among polydrug users in Brazil: A biological survey using respondent driven sampling. AIDS and Behavior, 22(7), 2089–2103.
   PubMed Web of Science ®Google Scholar
• Braga, W. S., Castilho, M. C., Borges, F. G., Martinho, A. C. S., Rodrigues, I. S., Azevedo, E. P., Scazufca, M., & Menezes, P. R. (2012). Prevalence of hepatitis B virus infection and carriage after nineteen years of vaccination program in the Western Brazilian Amazon. Revista da Sociedade Brasileira de Medicina Tropical, 45(1), 13–17. doi:10.1590/S0037-86822012000100004
   PubMed Web of Science ®Google Scholar
• Castilho, M. C., Oliveira, C. M., Gimaque, J. B., Leão, J. D., & Braga, W. S. (2012). Epidemiology and molecular characterization of hepatitis B virus infection in isolated villages in the Western Brazilian Amazon. The American Journal of Tropical Medicine and Hygiene, 87(4), 768–774. doi:10.4269/ajtmh.2012.12-0083
   PubMed Web of Science ®Google Scholar
• Chen, F., Zhang, J., Guo, F., Wen, B., Luo, S., Yuan, D., Lin, Y., Ou, W., Tang, P., Dai, G., Li, F., Liu, W., & Qu, X. (2017). HBV, HCV and HDV infection shows distinct patterns between injection drug users and general population. Journal of Gastroenterology and Hepatology, 32(2), 515–520. doi:10.1111/jgh.13460
   PubMed Web of Science ®Google Scholar
• Cruz, M. S., Andrade, T., Bastos, F. I., Leal, E., Bertoni, N., Villar, L. M., Tiesmaki, M., & Fischer, B. (2013). Key drug use, health and socio-economic characteristics of young crack users in two Brazilian cities. International Journal of Drug Policy, 24(5), 432–438. doi:10.1016/j.drugpo.2013.03.012
   PubMed Web of Science ®Google Scholar
• da Silva, L. N., da Silva França, D. D., Del-Rio, N. H. A., Dos Santos Carneiro, M. A., Martins, R. M. B., Guimarães, R. A., Pinheiro, R. S., … Teles, S. A. (2017). Low prevalence, low immunization and low adherence to full hepatitis B vaccine scheme and high-risk behaviors among crack cocaine users in central Brazil. Journal of Infection and Public Health, 10(1), 76–83. doi:10.1016/j.jiph.2016.02.010
   PubMed Web of Science ®Google Scholar
• de Castro Sant’ Anna, C., de Almeida, M. K. C., Ferreira, P., de Oliveira, R. G., Ferreira Baraúna, A. R., Costa Gonçalvez, E., Marinho da Silva, A., … Martins, L. C. (2018). Prevalence of occult hepatitis B in a population from the Brazilian Amazon region. Journal of Medical Virology, 90(6), 1063–1070. doi:10.1002/jmv.25051
   PubMed Web of Science ®Google Scholar
• Ferreira, R. C., Rodrigues, F. P., Teles, S. A., Lopes, C. L., Motta-Castro, A. R., Novais, A. C. M., Souto, F. J. D., & Martins, R. M. B. (2009). Prevalence of hepatitis B virus and risk factors in Brazilian non-injecting drug users. Journal of Medical Virology, 81(4), 602–609. doi:10.1002/jmv.21464
   PubMed Web of Science ®Google Scholar
• Frade, P. C. R., Raiol, N. C., da Costa, L. M., Pinheiro, L. M., Silva-Oliveira, G. C., Pinho, J. R., Martins, L. C., Lemos, J. A., & Oliveira-Filho, A. B. (2019). Prevalence and genotyping of hepatitis B virus: A cross-sectional study conducted with female sex workers in the Marajó Archipelago. International Journal of STD & Aids, 30(9), 902–910. doi:10.1177/0956462419849252
   PubMed Web of Science ®Google Scholar
• Gaspar, I. R., Magalhães, M. J. O., Sousa, V. A., Castro, J. A. A., Amaral, C. E. M., Hermes, R. B., Fischer, B., Pinho, J. R. R., Lemos, J. A. R., & Oliveira-Filho, A. B. (2016). Epidemiology of hepatitis B virus infection among non-injecting drug users in the state of Pará, Brazilian Amazon. In T. Reid (Ed.), Substance abuse: influences, treatment options and health effects (pp. 95–108). Nova Science Publishers.
   Google Scholar
• Lampe, E., Mello, F. C. A., do Espírito-Santo, M. P., Oliveira, C. M. C., Bertolini, D. A., Gonçales, N. S. L., Moreira, R. C., … Pardini, M. I. M. C. (2017). Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: A 1000-sample multicenter study. Journal of General Virology, 98(6), 1389–1398. doi:10.1099/jgv.0.000789
   PubMed Web of Science ®Google Scholar
• Liaw, Y. F. (2009). Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver International, 29, 100–107. doi:10.1111/j.1478-3231.2008.01941.x
   PubMed Web of Science ®Google Scholar
• Makvandi, M. (2016). Update on occult hepatitis B virus infection. World Journal of Gastroenterology, 22(39), 8720–8734. doi:10.3748/wjg.v22.i39.8720
   PubMed Web of Science ®Google Scholar
• Matos, M. A., Ferreira, R. C., Rodrigues, F. P., Marinho, T. A., Lopes, C. L., Novais, A. C. M., Motta-Castro, A. R. C., Teles, S. A., Souto, F. J. D., & Martins, R. M. B. (2013). Occult hepatitis B virus infection among injecting drug users in the Central-West Region of Brazil. Memórias Do Instituto Oswaldo Cruz, 108(3), 386–389. doi:10.1590/S0074-02762013000300019
   Web of Science ®Google Scholar
• Matos, M. A., França, D. D. S., Carneiro, M. A. S., Martins, R. M.B., Kerr, L. R. F. S., Caetano, K. A. A., Pinheiro, R. S., Araújo, L. A., Mota, R. M. S., Matos, M. A. D., Motta-Castro, A. R. C, & Teles, S. A. (2017). Viral hepatitis in female sex workers using the Respondent-Driven Sampling. Revista de Saúde Pública, 51, 65. doi:10.1590/S1518-8787.2017051006540
   Google Scholar
• Nunes, C. L., Andrade, T., Galvão-Castro, B., Bastos, F. I., & Reingold, A. (2007). Assessing risk behaviors and prevalence of sexually transmitted and blood-borne infections among female crack cocaine users in Salvador-Bahia, Brazil. Brazilian Journal of Infectious Diseases, 11(6), 561–566. doi:10.1590/S1413-86702007000600007
   PubMed Web of Science ®Google Scholar
• Oliveira, E. H., Verde, R. M. L., Pinheiro, L. M. L., Benchimol, M. G., Aragão, A. L. E. D., Lemos, J. A., Vallinoto, A. C. R., & Oliveira-Filho, A. B. (2014). HBV infection in HIV-infected subjects in the state of Piauí, Northeast Brazil. Archives of Virology, 159(5), 1193–1197. doi:10.1007/s00705-013-1921-2
   PubMed Web of Science ®Google Scholar
• Oliveira, M. L., Bastos, F. I., Telles, P. R., Yoshida, C. F., Schatzmayr, H. G., Paetzold, U., Pauli, G., & Schreier, E. (1999). Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil. Brazilian Journal of Medical and Biological Research, 32(9), 1107–1114. doi:10.1590/S0100-879X1999000900009
   PubMed Web of Science ®Google Scholar
• Oliveira, S. A., Hacker, M. A., Oliveira, M. L., Yoshida, C. F., Telles, P. R., & Bastos, F. I. (2005). A window of opportunity: Declining rates of hepatitis B virus infection among injection drug users in Rio de Janeiro, and prospects for targeted hepatitis B vaccination. Revista Panamericana de Salud Pública, 18(4-5), 271–277. doi:10.1590/S1020-49892005000900007
   PubMed Web of Science ®Google Scholar
• Oliveira-Filho, A. B., Santos, F. J. A., Silva, F. Q., Raiol, N. C., Costa, C. C. S., Piauiense, J. N. F., Martins, L. C., … Fischer, B. (2019). Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region. BMC Infectious Diseases, 19(1), 634. doi:10.1186/s12879-019-4270-2
   PubMedGoogle Scholar
• Paraná, R., & Almeida, D. (2005). HBV epidemiology in Latin America. Journal of Clinical Virology, 34, S130–S133. doi:10.1016/S1386-6532(05)80022-8
   PubMed Web of Science ®Google Scholar
• Pereira, L. M., Martelli, C. M., Merchán-Hamann, E., Montarroyos, U. R., Braga, M. C., de Lima, M. L., Cardoso, M. R., …Hepatitis, S. G. (2009). Population-based multicentric survey of hepatitis B infection and risk factor differences among three regions in Brazil. The American Journal of Tropical Medicine and Hygiene, 81(2), 240–247. doi:10.4269/ajtmh.2009.81.240
   PubMed Web of Science ®Google Scholar
• Piauense, J. N. F., Costa, C. C. S., Cordeiro, A. C. C., Frade, P. C. R., Silva-Oliveira, G. C., Resque, R. L., Kupek, E., & Oliveira-Filho, A. B. (2019). Actions and strategies for the control and prevention of hepatitis B virus infection in people who use illicit drugs in northern Brazil. In: Santana,, M. L., editor. Mental health: theory and intervention., Atena Editora.. 1–10. doi:10.22533/at.ed.3661918121
   Google Scholar
• Removille, N., Origer, A., Couffignal, S., Vaillant, M., Schmit, J. C., & Lair, M. L. (2011). A hepatitis A, B, C and HIV prevalence and risk factor study in ever injecting and non-injecting drug users in Luxembourg associated with HAV and HBV immunisations. BMC Public Health, 11(1), 351. doi:10.1186/1471-2458-11-351
   PubMedGoogle Scholar
• Rosa, A. D. S., & Santana, C. L. A. (2018). Street Clinic as good practice in Collective Health. Revista Brasileira de Enfermagem, 71(suppl 1), 465–466. doi:10.1590/0034-7167-201871sup102
   PubMedGoogle Scholar
• Said, Z. N. (2011). An overview of occult hepatitis B virus infection. World Journal of Gastroenterology, 17(15), 1927–1938. doi:10.3748/wjg.v17.i15.1927
   PubMed Web of Science ®Google Scholar
• Silva, F. Q., Santos, F. J. A., Andrade, A. P., Pacheco, S. D. B., Fischer, B., Pinho, J. R. R., Lemos, J. A. R., & Oliveira-Filho, A. B. (2018). Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon. Archives of Virology, 163(3), 617–622. doi:10.1007/s00705-017-3656-y
   PubMed Web of Science ®Google Scholar
• Souto, F. J. (2015). Distribution of hepatitis B infection in Brazil: The epidemiological situation at the beginning of the 21st century. Revista da Sociedade Brasileira de Medicina Tropical, 49(1), 11–23. doi:10.1590/0037-8682-0176-2015
   PubMed Web of Science ®Google Scholar
• Tanwar, S., & Dusheiko, G. (2012). Is there any value to hepatitis B virus genotype analysis? Current Gastroenterology Reports, 14(1), 37–46. doi:10.1007/s11894-011-0233-5
   PubMedGoogle Scholar
• Tong, S., & Revill, P. (2016). Overview of viral replication and genetic variability. Journal of Hepatology, 64(1), S4–S16. doi:10.1016/j.jhep.2016.01.027
   PubMedGoogle Scholar
• Trepo, C., Chan, H. L., & Lok, A. (2014). Hepatitis B virus infection. The Lancet, 384(9959), 2053–2063. doi:10.1016/S0140-6736(14)60220-8
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2018). Hepatitis B. WHO’s publications. Retrieved March 27, 2019, from https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b
   Google Scholar